| 1 |
Ajebo G, Patel SJ, Kota V, et al. A nationwide analysis of outcomes of stroke in hospitalized patients with essential thrombocythemia: 2006 to 2014 [J]. Am J Blood Res, 2020, 10(4): 76-81.
|
| 2 |
Barbui T, Falanga A. Molecular biomarkers of thrombosis in myeloproliferative neoplasms [J]. Thromb Res, 2016, 140(Suppl 1): S71-S75.
|
| 3 |
Desai I, Tiwari A, Singh MK, et al. Successful thrombolysis in essential thrombocythemia-related acute ischaemic stroke [J]. BMJ Case Rep, 2021, 14(5): e242925.
|
| 4 |
Titmarsh GJ, Duncombe AS, McMullin MF, et al. How common are myeloproliferative neoplasms? A systematic review and meta-analysis [J]. Am J Hematol, 2014, 89(6): 581-587.
|
| 5 |
Aruch D, Mascarenhas J. Contemporary approach to essential thrombocythemia and polycythemia vera [J]. Curr Opin Hematol, 2016, 23(2): 150-160.
|
| 6 |
Stefanou MI, Richter H, Härtig F, et al. Recurrent ischaemic cerebrovascular events as presenting manifestations of myeloproliferative neoplasms [J]. Eur J Neurol, 2019, 26(6): 903-e64.
|
| 7 |
韩雪, 白贝贝, 王春健, 等. 真性红细胞增多症和原发性血小板增多症患者发生再次血栓事件的危险因素分析 [J]. 中华血液学杂志, 2019, 40(1): 17-23.
|
| 8 |
Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management [J]. Am J Hematol, 2019, 94(1): 133-143.
|
| 9 |
刘玲, 罗根培, 范进, 等. 以椎-基底动脉系统短暂性脑缺血发作为首发表现的原发性血小板增多症的诊治 [J/CD]. 中华脑血管病杂志（电子版）, 2010, 4(1): 46-52.
|
| 10 |
Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia [J]. Blood, 2016, 127(20): 2391-2405.
|
| 11 |
Falanga A, Marchetti M. Thrombotic disease in the myeloproliferative neoplasms [J]. Hematology Am Soc Hematol Educ Program, 2012, 2012: 571-581.
|
| 12 |
Chen L, Li J, Tai H. Essential thrombocythemia-related stroke and improvement with tissue plasminogen activator[J]. Am J Med Sci, 2015, 350(2): 152.
|
| 13 |
Ogata J, Yonemura K, Kimura K, et al. Cerebral infarction associated with essential thrombocythemia: an autopsy case study [J]. Cerebrovasc Dis, 2005, 19(3): 201-205.
|
| 14 |
Das S, Deb A, Pal T. Antithrombotic management in ischemic stroke with essential thrombocythemia: current evidence and dilemmas [J]. Med Princ Pract, 2021, 30(5): 412-421.
|
| 15 |
Tefferi A, Pardanani A. Essential thrombocythemia [J]. N Engl J Med, 2019, 381(22): 2135-2144.
|
| 16 |
Ferro JM, Infante J. Cerebrovascular manifestations in hematological diseases: an update [J]. J Neurol, 2021, 268(9): 3480-3492.
|
| 17 |
Shirahama K, Inatomi Y, Yonehara T, et al. Recurrence of embolic stroke during intravenous thrombolysis [J]. J Stroke Cerebrovasc Dis, 2012, 21(1): 84-86.
|
| 18 |
Gensicke H, Al Sultan AS, Strbian D, et al. Intravenous thrombolysis and platelet count [J]. Neurology, 2018, 90(8): e690-e697.
|